Cytogenetic abnormalities in multiple myeloma patients according to age: A real-world study by the Nordic Myeloma Study Group
Br J Haematol
.
2025 Oct;207(4):1638-1642.
doi: 10.1111/bjh.70030.
Epub 2025 Jul 23.
Authors
Sigrún Thorsteinsdóttir
1
2
,
Konstantinos Lemonakis
3
,
Tobias S Slørdahl
4
5
,
Sæmundur Rögnvaldsson
1
,
Anna Karen Richardson
1
,
Emil Hermansen
2
,
Jonathan Thorsen
6
,
Fredrik Schjesvold
7
,
Kari Lenita Falck Moore
7
8
9
10
,
Agoston Gyula Szabo
2
,
Mette K Andersen
11
,
Anders Waage
5
12
,
Cecilie Hveding Blimark
13
,
Annette Vangsted
2
;
Nordic Myeloma Study Group
Affiliations
1
Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
2
Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
3
Department of Hematology, Skane University Hospital Malmo/Lund, Sweden.
4
Department of Hematology, St. Olavs Hospital-Trondheim University Hospital, Trondheim, Norway.
5
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
6
Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
7
Oslo Myeloma Centre, Department of Hematology, Oslo University Hospital, Oslo, Norway.
8
Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway.
9
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
10
KG Jebsen Centre for B Cell Malignancies, University of Oslo, Oslo, Norway.
11
Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark.
12
Reserch Department, St. Olavs Hospital-Trondheim University Hospital, Trondheim, Norway.
13
Department of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden.
PMID:
41070698
PMCID:
PMC12512085
DOI:
10.1111/bjh.70030
No abstract available
Keywords:
cytogenetics; elderly; multiple myeloma; myeloma; prognosis.
Grants and funding
Nordic Myeloma Study Group
Rigshospitalet's Research Foundation